We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+18.11%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$169M
Cap. Flow
+$103M
Cap. Flow %
19.96%
Top 10 Hldgs %
26.88%
Holding
503
New
57
Increased
239
Reduced
90
Closed
78

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.25M
2
GILD icon
Gilead Sciences
GILD
+$6.13M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$6.05M
4
AMGN icon
Amgen
AMGN
+$5.9M
5
ADBE icon
Adobe
ADBE
+$5.02M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.85M
2
ADI icon
Analog Devices
ADI
+$3.37M
3
AMZN icon
Amazon
AMZN
+$3.21M
4
LULU icon
lululemon athletica
LULU
+$2.87M
5
ORCL icon
Oracle
ORCL
+$1.91M

Sector Composition

Rank Sector Weight
1 Technology 34.39%
2 Healthcare 30.05%
3 Consumer Discretionary 17.55%
4 Communication Services 6.11%
5 Consumer Staples 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGMO
476
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-4,546
Closed -$2.73K
STAA icon
477
STAAR Surgical
STAA
$1.27B
– –
-1,067
Closed -$42.9K
STOK icon
478
Stoke Therapeutics
STOK
$2.13B
– –
-1,132
Closed -$4.46K
STRO icon
479
Sutro Biopharma
STRO
$353M
– –
-155
Closed -$5.37K
TAL icon
480
TAL Education Group
TAL
$6.58B
– –
-300
Closed -$2.73K
TCRT icon
481
Alaunos Therapeutics
TCRT
$4.88M
– –
-41
Closed -$815
TIL icon
482
Instil Bio
TIL
$50.7M
– –
-167
Closed -$1.43K
TSVT
483
DELISTED
2seventy bio
TSVT
– –
-1,300
Closed -$5.1K
LENZ
484
LENZ Therapeutics
LENZ
$158M
– –
-212
Closed -$3.68K
KLRS
485
Kalaris Therapeutics
KLRS
$93.7M
– –
-127
Closed -$6.27K
TVRD
486
Tvardi Therapeutics
TVRD
$22.1M
– –
-39
Closed -$2.33K
OMGA
487
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
– –
-1,414
Closed -$3.04K
PSTX
488
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
– –
-2,225
Closed -$5.3K
GRTS
489
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
– –
-2,392
Closed -$4.11K
EGRX
490
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-334
Closed -$5.27K
GTHX
491
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
– –
-1,331
Closed -$1.92K
HLTH
492
DELISTED
Cue Health Inc. Common Stock
HLTH
– –
-3,936
Closed -$1.74K
SWAV
493
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
– –
-1,551
Closed -$309K
EIGR
494
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-38
Closed -$346
NGM
495
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
– –
-2,122
Closed -$2.27K
KNTE
496
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
– –
-1,201
Closed -$1.68K
NSTG
497
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-1,212
Closed -$2.08K
SGEN
498
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-5,520
Closed -$1.17M
ABCM
499
DELISTED
Abcam PLC
ABCM
– –
-5,513
Closed -$125K
EQRX
500
DELISTED
EQRx, Inc. Common Stock
EQRX
– –
-12,513
Closed -$27.8K
17 18 19
20
21

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q4 2023 Portfolio in Review

As of Q4 2023, China Universal Asset Management Company held 503 positions worth $514M, up 49% from $345M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

China Universal Asset Management Company deployed $103M of net new capital in Q4 2023, opening 57 new positions and adding to 239 existing holdings. Its largest new stake was GSK: 54,345 shares worth $2.03M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $4.85M trimmed.

  • China Universal Asset Management Company's largest Q4 2023 buy was GSK: 54,345 shares worth $2.03M.
  • China Universal Asset Management Company added most to Vertex Pharmaceuticals in Q4 2023, an estimated $6.25M increase.
  • China Universal Asset Management Company's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $4.85M.
  • China Universal Asset Management Company fully exited Oracle in Q4 2023, selling an estimated $1.91M.
  • China Universal Asset Management Company's ten largest holdings make up 27% of its $514M portfolio in Q4 2023.
  • China Universal Asset Management Company opened 57 new positions and closed 78 in Q4 2023.
  • China Universal Asset Management Company's portfolio value rose 49% quarter-over-quarter to $514M.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.